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Among the three related L, M, and S envelope proteins of the hepatitis B virus (HBV), the L and S polypeptides are required
for virion production. Whereas the pivotal function of the pre-S region of L in nucleocapsid envelopment has been
established, the contribution of its S domain and the S protein is less clear. In this study, we evaluated the role of the cytosolic
S loop, common to L and S, in HBV assembly by performing mutagenesis experiments. To distinguish between the effect of
the mutations on either envelope or virion formation, we investigated the ability of the mutants to assemble into secretable
subviral empty envelopes and to replace the wild-type proteins in virion maturation, respectively. Virion production was found
to be blocked by each of the secretion-competent deletion and substitution mutants SD35–39, SD40–46, SD50–56, and
Ss56–59, while an insertion within the loop is tolerated. Surprisingly, single mutations of the arginines terminating the loop
had an opposite effect: while a conservative exchange of Arg-73 still allowed virion formation, the same mutation of Arg-79
did not. The critical sequences and/or structural requirements of the cytosolic S loop involved in nucleocapsid envelopment
primarily act in the S background. These findings can be related to a model for a synergistical function of both L and S
proteins in HBV morphogenesis. © 2000 Academic PressINTRODUCTION
Enveloped viruses contain a nucleocapsid surrounded
by a lipid coat which accommodates the viral membrane
proteins. This envelope is formed by budding of the
nucleocapsid through cellular membranes. For most vi-
ruses, the specificity of the assembly process is deter-
mined by interactions between the viral envelope pro-
teins and the nucleocapsid or matrix proteins (reviewed
in Garoff et al., 1998).
The assembly of the hepatitis B virus (HBV) is thought
to occur at post-ER/pre-Golgi membranes where pre-
formed cytosolic nucleocapsids, enclosing the circular,
partially double-stranded DNA genome 3.2 kb in length
and the viral polymerase, are packaged by the trans-
membrane viral envelope proteins (Bruss and Ganem,
1991; Ueda et al., 1991; Huovila et al., 1992). Virions then
bud into intraluminal cisternae and leave the cell via the
constitutive pathway of secretion. As a peculiarity of an
HBV infection, an excess of envelope proteins, however,
is not incorporated into virion envelopes but self-assem-
bles into secreted subviral lipoprotein particles, known
as hepatitis B surface antigen (HBsAg) particles or empty
envelopes (Heermann and Gerlich, 1991). The HBV en-
velope contains three closely related proteins, the large
L, middle M, and small S envelope proteins which are
encoded in a single open-reading frame of the viral
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358genome by means of three different start codons and a
common stop codon. Accordingly, the 226-amino acid
(aa) sequence of the S protein is also present at the
C-termini of the M and L proteins. The M protein has an
N-terminal extension of 55 aa, referred to as the pre-S2
region, while the L protein is additionally extended at its
amino-terminus by 108 aa (or 119 aa, depending on
serotype), corresponding to the pre-S1 region (see Fig.
1A) (reviewed in Heermann and Gerlich, 1991; Nassal,
1996).
The envelope proteins are synthesized as polytopic
membrane proteins of the endoplasmic reticulum (ER)
membrane which they span at two topogenic segments
(signals I and II) and probably at the apolar C-terminus of
their S domains (see Fig. 1B) (Eble et al., 1987; Stirk et al.,
1992). These signals also govern the cotranslational
translocation of the upstream N-termini of the S and M
proteins, and in particular of the pre-S2 region of M into
the ER lumen (Eble et al., 1990). Conversely, the L protein
adopts two transmembrane topologies as it disposes its
pre-S (pre-S1 plus pre-S2) domain to both the cytosolic
(internal in the secreted envelope, i-pre-S) and the lumi-
nal (external in the secreted envelope, e-pre-S) sides of
the membrane due to a yet uncharacterized process of
partial posttranslational translocation across mem-
branes (Ostapchuk et al., 1994; Bruss et al., 1994; Prange
and Streeck, 1995). Hence, the type I signal of L does not
cross the membrane in the i-pre-S isoform, while the
remaining sequences of the S domain appear to be
organized similar to the M and S proteins.
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359ENVELOPE S DOMAIN IN HBV ASSEMBLYThe three envelope proteins contribute differently to
subviral and viral particle formation. Assembly and se-
cretion of subviral particles are solely driven by the S
protein, but also sustained by the M protein while being
blocked by the L protein due to the L-specific retention
motifs (Kuroki et al., 1989; Prange et al., 1991; Gallina et
l., 1995). By contrast, the L protein along with its split
opology is obviously the key player in virion formation
Bruss and Ganem, 1991; Ueda et al., 1991; Bruss and
ieluf, 1995). The S protein is required but not sufficient
or this process, whereas the M protein seems to be
FIG. 1. (A) Gene and domain structure of the HBV envelope proteins.
The L, M, and S envelope proteins are translated from a single open-
reading frame of HBV by use of three in-frame initiation sites at the
N-termini of pre-S1, pre-S2, and S which are indicated by arrows. All
three proteins share the 226-aa sequence of the S domain. The 55-aa
long pre-S2 domain is common to M and L, while the L protein
additionally contains the N-terminal pre-S1 domain consisting of 108
aa. (B) Proposed topology of the S protein in the ER membrane and
schematic representation of mutant envelope proteins. The predicted
four membrane-spanning segments of S project its N- and C-terminus
into the ER lumen (Stirk et al., 1992); the first two segments with
topogenic properties are indicated by “I” and “II”. Below, the wild-type
(wt) aa sequence of the cytosolic S loop, connecting these segments,
is shown in single letter code. The name and sequence of each mutant
are listed further below. Deleted residues are indicated by lines; sub-
stituting residues are shown in bold and underlined characters. “X”
indicates that the corresponding aa was replaced by either of the
residues shown in the name of the mutant. The sequence of the foreign
sequence (“Polio”), inserted between aa positions 50 and 51, is shown
in the box.ispensable (Bruss and Ganem, 1991; Fernholz et al., p993). The pivotal role of the L protein in virus assembly
s related to its unique topology, as its internal (cytosolic)
re-S domain has been shown to be needed for envel-
pment of cytosolic nucleocapsids (Bruss and Vieluf,
995). Furthermore, potential docking sites for the capsid
ave been mapped within a short linear sequence over-
apping the pre-S1–pre-S2 region of L (between aa 92 to
08 of pre-S1 and aa 1 to 5 of pre-S2) while the remaining
arts of the pre-S domain are dispensable for virion
roduction (Bruss, 1997; Le Seyec et al., 1998, 1999).
hether the S domain of L is additionally involved in
ackaging of the nucleocapsid is unclear. A candidate S
rotein domain that is exposed to the cytosol and thus
ccessible to the nucleocapsid is a hydrophilic se-
uence spanning signals I and II (see Fig. 1B) (Eble et al.,
987; Stirk et al., 1992). Indeed, recent in vitro-binding
xperiments with synthetic peptides or envelope pro-
eins synthesized in a cell-free system and viral capsids
ndicate that this cytosolic S loop may mediate contacts
etween the virus envelope and the nucleocapsid pro-
ein during HBV assembly (Poisson et al., 1997; Tan et al.,
999).
To investigate a role for the cytosolic S loop of the
nvelope proteins as a matrix domain in virion morpho-
enesis, we created a set of deletions, substitutions, and
n insertion within this region. The impact of certain
mino acids on capsid envelopment was analyzed with a
eries of specific amino acid mutations. The mutations
ere introduced into the loop of both the S protein and
he L protein in order to evaluate the ability of the mod-
fied proteins to assemble into secretable subviral parti-
les and to substitute for the wild-type forms in virion
ormation upon transfection of human hepatoma cell
ines.
RESULTS
Experimental outline. In an effort to understand the
unction of the cytosolic S loop of the HBV envelope
roteins in the morphogenesis of subviral and viral par-
icles, we constructed a series of mutants within this
egion, encompassing aa residues 33 to 79 of the S
omain. To identify sequences essential or dispensable
or assembly and secretion of subviral particles, mutant
roteins were analyzed by transient expression in COS-7
ells. Secretion-competent mutants were then tested for
heir ability to replace the wild-type forms in the envel-
pment of nucleocapsids by using trans-complementa-
ion of cloned HBV genomes that are competent for
eplication upon transfection of human hepatoma cell
ines (Sureau et al., 1986) but are defective in envelope
rotein synthesis.
Effects of S protein mutations on secretion of subviral
articles. The alterations introduced in the cytosolic S
oop are depicted in Fig. 1 and are designated by the
osition(s) and types of the mutations. For simplification,
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360 LO¨FFLER-MARY ET AL.aa numbering used herein will refer to the envelope
protein domains (pre-S1, pre-S2, and S) rather than to
consecutive numbering of the proteins. To study the
effect of the mutations for assembly and secretion of
empty envelopes, mutant S genes were transiently ex-
pressed in COS-7 cells from the human metallothionein
IIA (hMT) promoter, and the amounts of S proteins syn-
thesized and secreted from transfected cells were deter-
mined by ELISA (Table 1). As we have reported previ-
ously (Prange et al., 1992), deletions within the N-termi-
nal part of the loop did not affect subviral particle
release, since each of the deletion mutants SD35–39,
D40–46, and SD50–56 could be identified in cellular
ysates and supernatants at ratios almost identical to
hose for the wild-type S protein (Table 1). Conversely,
imilar-sized deletions in the C-terminal half of the loop
mpaired synthesis and/or protein stability and blocked
ecretion, as mutants SD57–63 and SD71–78 could be
nly detected intracellularly (Table 1).
In an attempt to obtain secretion-competent S mutants
ithin the latter region, we have now constructed a
eries of consecutive substitutions within the aa se-
uence 56 to 71 of S, thereby leaving the His-60, Cys-65,
nd Cys-69 residues which have been shown to be
ssential for assembly and secretion of subviral particles
Mangold and Streeck, 1993). As diagrammed in Fig. 1B,
utants Ss56–59, Ss61–64, Ss66–68, and Ss70–71 con-
tained substitutions of the indicated amino acid positions
which have been replaced by alanines and leucines. Out
of these mutants, however, only Ss56–59 displayed a
ecretory phenotype, while the remaining substitutions
TABLE 1
Synthesis and Secretion of Wild-Type
and Mutant S Envelope Proteins
Wild-type and mutant S proteins
Concentration of HBsAg (ng/ml)
Intracellular Extracellular
S wt 50 53
SD35–39 50 36
SD40–46 46 50
SD50–56 44 40
SD57–63 22 0
SD71–78 13 0
Ss56–59 54 47
Ss61–64 35 0
Ss66–68 42 0
Ss70–71 27 0
S.R73L 32 0
S.R73K 51 45
S.R78A 34 0
S.R78K 35 0
S.R79A 29 0
S.R79K 49 45
S::Polio 56 58ompletely abolished subviral particle export (Table 1). In csecond mutagenesis approach, we assayed the func-
ion of the cluster of positively charged residues on
mpty envelope secretion which are located at the junc-
ion of the cytosolic loop and the second transmembrane
ype II domain of S (Fig. 1B), and which are deleted in the
ecretion-defective mutant SD71–78. Therefore, each of
he three arginine residues, Arg-73, Arg-78, and Arg-79,
as individually mutated to uncharged amino acids, like
lanine or leucine (Fig. 1B). In addition, mutations were
onstructed introducing amino acid residues of the same
harge by using lysine as the substituting residue (Fig.
B). Expression of the mutant S genes in transfected
ells revealed that mutation of Arg-73 to lysine (S.R73K)
s tolerated but not to leucine (S.R73L) (Table 1), indicat-
ng that a positive charge is required in this position for
he secretion of subviral particles. Identical results were
btained for the Arg-79 mutations, as this arginine resi-
ue could be substituted by lysine (S.R79K) but not by
lanine (S.R79A). In contrast, the Arg-78 was found to be
ntirely indispensable for subviral particle secretion and
ould not even be changed to lysine (S.R78K) (Table 1).
Finally, a mutant carrying an insertion of a poliovirus
pitope, 12 aa in length, in the mid of the cytosolic S loop
as included in our analysis (S::Polio; see Fig. 1B). As
as been reported previously (Delpeyroux et al., 1990),
his insertion affected neither assembly nor secretion of
mpty envelopes (Table 1).
Effects of S domain mutations on secretion of viral
articles. Formation of hepatitis B virus particles requires
he L envelope protein in addition to the S protein. To test
hether the mutant S proteins, described above, could
unction in virion morphogenesis, the mutations had
herefore to be simultaneously introduced into the L-
ncoding region, since the L protein shares the entire
equence of the S protein. However, due to the genetic
rganization of the HBV genome, the insertion of these
utations would disrupt the overlapping open-reading
rame of the viral polymerase (see Fig. 3A). Therefore, the
-specific mutations were introduced into the L gene
resent in plasmid pNI2.L that directs L protein expres-
ion from the hMT IIA promoter. These constructs were
hen used as cotransfecting plasmids with a cloned
eplication-competent HBV genome (Radziwill et al.,
990) which is deficient to drive envelope protein syn-
hesis because the L, M, and S translational start codons
ave been inactivated by mutagenesis (HBV.env2, see
ig. 3A). It should be noted that each of these knockout
utations remained silent in the overlapping polymerase
ene. Using this approach, the capacity of the mutant
nvelope proteins to substitute for the wild-type forms in
iral morphogenesis can be studied.
As a prerequisite of this approach, the mutant protein
ust be expressed efficiently. To investigate this point,
NI2.L-derived plasmids expressing the wild-type or mu-
ant L proteins were transiently transfected into COS-7
ells and intracellular viral proteins were analyzed by
361ENVELOPE S DOMAIN IN HBV ASSEMBLYimmunoprecipitation with an L-specific antiserum and
SDS-PAGE. As shown in Fig. 2, lysates of cells trans-
fected with the wild-type L gene contained the L polypep-
tide in the nonglycosylated (p39) and single-glycosylated
(gp42) form as a consequence of partial modification at
Asn-146 in its S domain (lane 1). In addition, minor
amounts both of the M (gp33/ggp36) and S (p24/gp27)
envelope proteins were obtained due to internal initiation
of translation. The M and S forms were likely coprecipi-
tated with the L protein since the HBV envelope proteins
have the characteristic of forming mixed oligomers upon
biosynthesis (Heermann and Gerlich, 1991). A virtually
identical pattern of immunoprecipitations was observed
with the mutant L proteins carrying lesions in the cyto-
solic loop of their S regions. In accord with their pre-
dicted molecular weights, the deletion mutants LsD35–
39, LsD40–46, and LsD50–56 displayed an increased
electrophoretic mobility, while the insertion mutant
Ls::Polio migrated slower than the wild-type (Fig. 2, lanes
3, 4, 5, and 2, respectively). As expected, mutant proteins
containing substitutions (Lss56–59, Ls.R73K, Ls.R73L,
and Ls.R79K) had the same molecular masses as com-
pared to wild-type L (Fig. 2, lanes 6, 7, 9, and 8, respec-
tively). All mutants were easily detectable, thus demon-
strating their overall efficient synthesis and stability.
To analyze the complementation ability of the mutant
proteins, the different L protein expression vectors were
cotransfected with the envelope-negative HBV genome
into HuH-7 cells. Although each of the L expression
vectors also gives raise to S (and M) protein synthesis
(see Fig. 2), the corresponding S (mutant) protein expres-
sion vectors were used as cotransfecting plasmids in
addition to ensure sufficient S protein synthesis. Produc-
FIG. 2. Stable expression of wild-type and mutant L proteins. COS-7
cells transfected with the indicated constructs were metabolically la-
beled and HBV envelope proteins were immunoprecipitated from cel-
lular lysates with an L-specific antiserum. Samples were analyzed by
electrophoresis through a 12.5% SDS-polyacrylamide gel and depicted
by PhosphorImager scanning. The M and S proteins, expressed from
their autologous promoter internal in the pre-S1 region, were coimmu-
noprecipitated with the L protein. Nonglycosylated (p) and glycosylated
(gp, ggp) forms of wild-type L, M, and S proteins are indicated.tion and secretion of virions from transfected cells weremonitored by immunoprecipitation of cellular superna-
tants with envelope-specific antisera, radioactive label-
ing of the partially double-stranded viral genome by the
endogenous polymerase of the virus, and detection of
the isolated genome by agarose gel electrophoresis and
PhosphorImager scanning. Similarly, intracellular nu-
cleocapsid assembly was investigated by using capsid-
specific antibodies for immunoprecipitation of cellular
lysates prior to the endogenous polymerase reaction
(EPR). As shown in Fig. 3C, transfection of the envelope-
defective HBV genome alone did not allow virion produc-
tion, as expected (lane 1). This defect could be comple-
mented in trans by cotransfection of the expression vec-
tors for the missing wild-type envelope proteins (Fig. 3C,
lane 2). Virion production could be also restored by the
Ls::Polio/S::Polio constructs carrying an insertion within
the cytosolic S loop (Fig. 3C, lane 10). Conversely, indi-
vidual deletions of amino acids 35–39, 40–46, or 50–56,
as well as the substitution of residues 56–59 all pre-
vented virion morphogenesis (Fig. 3C, lanes 3, 4, 5, and
9, respectively). Point mutations of the positive charged
residues flanking the cytosolic S loop at the distal site,
surprisingly, had an opposite effect on virion morphogen-
esis: while mutation of Arg-73 to lysine (R73K) still sup-
ported virus formation, the same mutation of Arg-79
(R79K) did not (Fig. 3C, lanes 6 and 7, respectively), thus
indicating the importance of the Arg-79 residue. For rea-
sons of control, the mutant R73L, that is defective in
subviral particle release in contrast to its R73K counter-
part, was included in this analysis. As expected, mutant
R73L was similarly defective in virus particle release
(Fig. 3C, lane 8). In parallel, assembly of HBV nucleocap-
sids within the transfected cells was monitored in order
to verify similar transfection efficiency and to exclude a
possible trans influence of the mutant envelope proteins
on capsid formation. As shown in Fig. 3C, all mutants
yielded signals of almost the same intensity as com-
pared to the wild-type proteins. This confirms that the
observed effects of the mutants on virus production
solely depended on their specific lesions. Taken to-
gether, these observations provide evidence that aa se-
quences 33 to 59 and the Arg-79 residue of the cytosolic
S loop of the HBV envelope proteins are required for
nucleocapsid budding.
Effects of L- and S-specific S domain mutations on
secretion of viral particles. Given that both the L and the
S envelope proteins are needed for virus assembly and
that both proteins carry the cytosolic S loop, we won-
dered whether or not both loops contribute to nucleo-
capsid envelopment. A distinct involvement of these re-
gions is conceivable because the folding pattern of the
loop may differ between the S and the L proteins and in
turn between the two isoforms of L. The loop of the
i-pre-S form of L (i.e., with cytosolic pre-S exposure) may
have an altered configuration relative to that of the e-
pre-S form (i.e., with luminal pre-S exposure), as its
t
p
t
c
a
p
a
w
c
(
f
e
T
i
m
t
g
(
s
t
i
362 LO¨FFLER-MARY ET AL.N-terminus is not anchored in the membrane through the
transmembrane type I signal. To address this issue, we
used cloned HBV genomes that are blocked in either S
(HBV.S2) or L (HBV.L2) protein synthesis. As expected,
FIG. 3. Complementation of an env-negative HBV genome. (A) Sche-
matic presentation of the basic plasmid construct pHBV.env2. The HBV
DNA, cloned as a 1.1 unit length (Radziwill et al., 1990), is shown as a
black bar. The human metallothionein promoter (hMT) is indicated by
an open arrow. Below, the open-reading frames for viral P (polymerase),
C (core), pre-S1–pre-S2–S (envelope), and X proteins are shown in
open boxes. To abolish L, M, and S envelope protein synthesis (L2, M2,
nd S2), the three in-frame AUG codons which precede the pre-S1,
re-S2, and S domains were simultaneously mutated, as indicated by
rrows. (B) Complementing plasmids. The wild-type L and S genes
ere provided by plasmids pNI2.L and pNI2.S, respectively, which
arry the genes under the transcriptional control of the hMT promoter.
C) Complementation assay. HuH-7 cells were transiently (co)trans-
ected with an env-negative HBV genome (pHBV.env2) and pNI2-based
xpression vectors for the L (pNI2.L) and S envelope proteins (pNI2.S).
he latter plasmids encode either the wild-type (wt) genes or the
ndicated mutant genes. Secretion of enveloped virions in the culture
edium was detected by immunoprecipitation of viral particles from
he medium with a mixture of L- and S-specific antisera. The viral
enomes were then labeled by the endogeneous polymerase reaction
EPR) and visualized by agarose electrophoresis and PhosphorImager
canning (upper panel). Cytosolic nucleocapsids were immunoprecipi-
ated from cellular lysates with a core-specific antiserum. The precip-
tated viral genomes were labeled by EPR as above (lower panel).these two constructs were unable to support virion for-
g
wmation but could be rescued by contransfecting the in-
dividual missing wild-type envelope protein expression
vector (Fig. 4). Next, cotransfections were performed with
plasmids encoding mutant envelope proteins that had an
inhibitory effect on virion assembly, as described above.
As shown for the substitution mutant s56–59, the S-
negative HBV genome could not be complemented by
mutant Ss56–59, although the L protein produced from
the genome contained the wild-type sequence of aa 56
to 59 (Fig. 4, lane 3). This indicates that residues 56 to 59
of the cytosolic loop of the S protein rather than those of
the L protein seem of critical importance for nucleocap-
sid envelopment. In support, cotransfection of the L-
negative genome with the Lss56–59 expression vector
restored virion production, albeit virus yield was less
compared to cotransfection with the parental plasmid
(Fig. 4, lanes 6 and 5, respectively; see also Fig. 5, lanes
4 and 5). As shown in the same figure, intracellular
nucleocapsids could be found in all transfections. Almost
identical results could be obtained for the deletion mu-
tants D35–39, D40–46, and D50–56 (data not shown).
From these data we conclude that sequences of the
cytosolic loop of the S protein are largely involved in HBV
morphogenesis.
This conclusion is further supported by the results of
complementation experiments which were performed in
FIG. 4. Complementation of mutant HBV genomes defective in S or
L envelope protein synthesis. HuH-7 cells were transfected with pHBV
derivatives in which either the translational start codon of the S protein
(pHBV.S2, lanes 1–3) or of the L protein (pHBV.L2, lanes 4–6) has been
inactivated. Accordingly, pHBV.S2-transfected cells still produce the L
and M envelope proteins while pHBV.L2-transfected cells synthesize
he S and M proteins. Cotransfections were done with pNI.2-based
lasmids carrying either the wild-type S (lane 2) or L (lane 5) gene, or
he indicated mutant genes (lanes 3 and 6). Virion release in the cell
ulture medium was analyzed by EPR labeling of precipitated viral
enomes (upper panel) as in Fig. 3C. Cellular lysates were precipitated
ith core-specific antiserum prior to the EPR (lower panel).
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363ENVELOPE S DOMAIN IN HBV ASSEMBLYorder to test whether or not mutant envelope proteins
might act as dominant negatives on virion production. To
this aim, the S-negative HBV genome was cotransfected
with both the mutant Ss56–59 and the wild-type S gene,
hile the L-defective genome was applied together with
he mutant Lss56–59 and wild-type L expression vectors.
s shown in Fig. 5, the defect of mutant Ss56–59 to
omplement the S-negative genome could not be res-
ued by coexpression of the wild-type S protein (lanes
–3), thus demonstrating that mutant Ss56–59 acts in a
ominant-negative manner on nucleocapsid envelop-
ent. By contrast, the correspondingly mutant Lss56–59
estored virion formation, irrespective of whether the
ild-type L protein was coexpressed or not (Fig. 5, lanes
–6). Altogether, this strongly indicates that the critical
equences of the cytosolic S loop involved in nucleocap-
id envelopment primarily exert their function in the S
ackground rather than in the S domain of the L protein.
DISCUSSION
The formation of hepatitis B virions is believed to be
riven by direct interactions between the viral envelope
FIG. 5. Complementation of mutant HBV genomes defective in S or
L envelope protein synthesis. Identical to Fig. 4, HuH-7 cells were
transfected with pHBV derivatives carrying either the S-negative (lanes
1–3) or L-negative (lanes 4–6) HBV genome. As denoted above each
lane, cotransfections were performed with expression vectors encod-
ing either the wild-type S (lane 1) or L (lane 4) gene, the mutant
Ss56–59 (lane 2) or Lss56–59 (lane 5) gene alone, or the mutant
s56–59 or Lss56–59 gene together with the wild-type S (lane 3) or L
lane 5) gene, respectively. Virions from the medium were detected by
PR labeling of precipitated viral genomes (upper panel), while intra-
ellular nucleocapsid assembly was analyzed by core-specific immu-
oprecipitation and EPR (lower panel).roteins and the preformed viral nucleocapsid since HBVacks a typical matrix protein that guides the assembly
rocess of, e.g., minus-stranded RNA viruses and retro-
iruses (reviewed in Garoff et al., 1998). In support of this
iew, previous work has demonstrated that the HBV L
nvelope protein contains an important assembly region
equired for nucleocapsid envelopment which is located
n its specific pre-S region (Bruss, 1997; Le Seyec et al.,
998, 1999). For functional activity, this sequence must be
rientated at the cytosolic face of the (post)ER mem-
rane, as ensured by the dual topology of the L protein
Ostapchuk et al., 1994; Bruss et al., 1994; Prange and
treeck, 1995; Bruss and Vieluf, 1995). The results pre-
ented in this study provide further evidence for matrix
rotein-like functions of HBV envelope polypeptide do-
ains, as we identified specific stretches of amino acids
nd even a single amino acid residue within the S do-
ain of the envelope proteins that are dispensable for
nvelope formation but are essential for virion produc-
ion.
We chose to investigate the cytosolic loop of the S
omain for its role in HBV morphogenesis because its
ocalization in the cytosol during synthesis (Eble et al.,
987; Stirk et al., 1992) is compatible with a direct inter-
ction with the nucleocapsid. A series of mutations was
reated in the cytosolic S loop of the L and the S protein
hich are both needed for virion growth (Bruss and
anem, 1991; Ueda et al., 1991). The introduction of the
utations into the S protein had the additional advan-
age that the mutant proteins could be tested not only for
tability but also for formation of empty envelopes and
heir extracellular release. The secretion competence
as used as an important criterion for an overall correct
olding of the peptide chain because misfolded proteins
re usually retained in the ER and, with respect to the
BV envelope proteins, would thus per se block virion
gress.
Consistent with the results of a mutational analysis
imed at identifying structural requirements of the S
rotein for envelopment of the hepatitis D viroid (Jenna
nd Sureau, 1998), our data show that the N-terminal half
aa 33 to 57) of the cytosolic S loop does not contain
otifs essential for the assembly and secretion of empty
nvelope particles with the known exception of Cys-48
Mangold and Streeck, 1993). As shown by the secretory
henotypes of mutants SD35–39, SD40–46, SD50–56,
Ss56–59, and S::Polio, small deletions, replacement of
pecific residues, and a 12-aa insertion were tolerated.
onversely, however, similar-sized deletions (SD57–63,
D71–78) and even smaller substitutions (Ss61–64,
s66–68, Ss70–71) in the C-terminal part of the cytosolic
S loop were found to be detrimental to envelope forma-
tion and secretion. Interestingly, within this region we
found the cluster of positively charged amino acids (Arg-
73, Arg-78, Arg-79), terminating the cytosolic loop and
thus preceding the transmembrane signal II, of critical
importance for empty envelope formation. Individual sub-
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364 LO¨FFLER-MARY ET AL.stitutions of each of the three arginines by uncharged
residues completely blocked subviral particle release
while replacements by amino acids of the same charge
were tolerated at positions 73 and 79 but not at position
78. We consider the need of these basic residues for
envelope formation likely to reflect the “positive inside”
rule which states that positively charged residues bor-
dering transmembrane segments direct the membrane
insertion and orientation of membrane proteins (von
Heijne, 1986). Accordingly, a change in the charge dis-
tribution may lead to an altered S domain protein topol-
ogy incompatible with envelope formation.
We next examined the impact of the lesions on virion
formation by analyzing the ability of the mutants to com-
plement an envelope-defective HBV genome in trans-
fected hepatoma cells. These results clearly revealed
that the N-terminal part of the cytosolic S loop (aa 33 to
59) contains motifs essential for nucleocapsid envelop-
ment, since neither of the deletion mutants SD35–39,
SD40–46, and SD50–56 nor the substitution mutant
Ss56–59 supported virion formation. Surprisingly, how-
ver, an insertion within this region (between aa 50 and
a 51) is tolerated, thus indicating that it remains func-
ional upon disruption of its continuous sequence. It
herefore seems less likely that this region (aa 33 to 59),
t least in all, constitutes a linear nucleocapsid-binding
lement. Rather, the overall folding of this region, seem-
ngly affected by the mutations except for the insertion,
ay contribute to virion production in forming a correctly
urved inner side of the envelope needed for its proper
resentation to the nucleocapsid. Such an interpretation
ay explain why a synthetic peptide corresponding to
esidues 31 to 55 of the cytosolic S loop failed to bind
BV capsids in vitro, while under the same assay con-
itions a peptide equivalent to the pre-S-specific assem-
ly domain of the L protein did (Poisson et al., 1997). With
he same binding assay, a direct nucleocapsid interac-
ion site has been further demonstrated for a peptide
overing the C-terminal part of the cytosolic S loop (aa 56
o 80) (Poisson et al., 1997). Consistent with this, we
herein now identified a single residue, the arginine at
osition 79, which is pivotal for virion growth.
The important role that charged residues play in HBV
orphogenesis and in envelope-nucleocapsid associa-
ion has been implicated by two recent works. First,
iopanning experiments with fusion phage display librar-
es have selected oligopeptides containing two con-
erved basic residues that bind to the tips of the spikes
f the HBV nucleocapsid; efficient binding of these pep-
ides depends on either of the two acidic residues at the
pike tips (Dyson and Murray, 1995; Bo¨ttcher et al., 1998).
econd, Tan et al. (1999) showed that mutations of the
wo arginines present in the pre-S-specific assembly
omain of the L protein (Arg-92 and Arg-102) dramatically
educed the binding affinity of in vitro-synthesized L pro-
eins for viral nucleocapsids. In this view, the charge crovided by the Arg-79 residue of the cytosolic S loop
ay synergistically specify the assembly process by
uiding an intimate interaction with its corresponding
arget on the nucleocapsid and by stabilizing the result-
ng virus particle. The particular role of Arg-79 is further
mphasized by the failure of the two nearby arginines
Arg-73 and Arg-78) to substitute for the missing residue,
hus indicating that the arginine residue must be pre-
isely positioned for function. In accord with this, our
ata revealed that the Arg-73 residue is less critical for
irion formation since this position is permissive for at
east a conservative exchange (R73K). Virion release,
owever, was blocked upon replacement of this arginine
y an uncharged residue (R73L). For reasons mentioned
bove, this is likely due to the defect of mutant R73L in
empty) envelope formation rather than to a defect in
ucleocapsid envelopment. Identical results were ob-
ained for all other secretion-defective mutant envelope
roteins analyzed herein (our unpublished observation).
his strongly indicates that the structural requirements of
he envelope proteins to build up the viral and subviral
nvelope are similar, which is in contrast to, e.g., the
ormation of coronavirus and coronavirus-like particles
De Haan et al., 1999).
Considering the shared domain structure of the HBV
envelope proteins, it is surprising that the L protein,
containing all envelope protein domains, is not sufficient
for virion assembly but requires the assistance of the S
protein (Bruss and Ganem, 1991; Ueda et al., 1991). To
account for the separate essential function of the S
protein, it has been suggested to form the scaffold of the
envelope thereby driving the morphogenetic process
similar to its function in empty envelope formation (Ueda
et al., 1991). Here we show that the S protein directly
participates in packaging of the nucleocapsid. As dem-
onstrated for the mutant s56–59, this substitution com-
pletely inhibited virion production when solely intro-
duced in the S protein, but less when only present in the
L protein. This phenonemon is best explained by differ-
ent secondary structures of at least this subdomain of
the two proteins. With regard to the dual topology of the
L protein, such a structural alteration of the cytosolic S
loops of the S and the L protein seems possible and may
thus render the S-specific loop as the favorite interaction
partner of the nucleocapsid. Therefore, it appears that
distinct elements, located within the pre-S-specific as-
sembly domain (Bruss, 1997; Le Seyec et al., 1998, 1999)
nd S-specific subdomains mapped herein, are opera-
ive on distinct envelope proteins during HBV morpho-
enesis.
Altogether, our data support and extend an attractive
odel that predicts a dual interaction of the HBV nucleo-
apsid with the envelope, as deduced from recent in vitro
poly)peptide/capsid-binding analyses (Poisson et al.,
997; Tan et al., 1999). Such a dual or even multiple
ross-recognition of viral substructures may facilitate
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365ENVELOPE S DOMAIN IN HBV ASSEMBLYassembly of HBV, thereby warranting its multiplication
even in the course of naturally occurring mutations af-
fecting putative assembly domains. The knowledge of
these assembly domains may help to disrupt the viral life
cycle, as HBV production in transfected cells has been
recently shown to be impaired by peptides, representing
mimics of the viral envelope (Bo¨ttcher et al., 1998). In this
egard, the Arg-79 residue of the cytosolic S loop may be
ne promising target for anti-viral intervention.
MATERIALS AND METHODS
Recombinant plasmids and site-directed mutagenesis.
or expression of the HBV envelope genes (subtype
yw), plasmids pNI2.L and pNI2.S carrying either the L
ene or the S gene, respectively, under the transcrip-
ional control of the hMT IIa promoter were used (Prange
nd Streeck, 1995). Construction of the deletion mutant
roteins SD35–39, SD40–46, SD50–56, SD57–63, and
D71–78 has been described previously (Prange et al.,
1992). The mutated DNA fragments were used to replace
the wild-type sequences contained within pNI2.S and
pNI2.L. For mutagenesis of the arginine residues at po-
sitions 73, 78, and 79, we used a recombinant M13mp19
bacteriophage carrying the 2.3-kb BglII-BglII fragment (nt
2839 to 1986) of wild-type HBV DNA. Site-directed
mutagenesis was performed by the phosphorothioate
method (Nakameye and Eckstein, 1986) with the
following antisense oligonucleotides: R73L, 59-
ACACATCCAGAGATATCCAGGACAAG-39; R73K, 59-
GACACATCCATTTATACCCGGGACAAGTGT-39; R78A,
59-AGATGATAAAGCGCGCCAGACACAT-39; R78K, 59-
GATAAAACGCTTAAGACACATC-39; R79K, 59-GAT-
GATAAACTTGCGCAGAC-39 ; R79A, 59-GATGATA-
AAAGCGCGCAGACACAT-39. For designation of each
mutation, the wild-type aa is indicated, and then its
position and the mutant aa are listed. In the DNA
sequences, the corresponding antisense codons are
underlined and boldface characters refer to mis-
matches. Mutations outside the underlined sequences
are genetically silent and indicate the incorporation of
diagnostic restriction sites. Fragments containing the
desired mutations were generated by cleavage with
XhoI (nt 129) and SpeI (nt 681) and used to substitute
for the corresponding wild-type sequences of the pa-
rental plasmids pNI2.S and pNI2.L.
The remaining substitutions were introduced by PCR.
The substitution of amino acids 56 to 59 of the S protein
was made by using the sense primer, s56–59, 59-TCT-
TGGCCAAAATTCGCAGTCCGCACTCGCCCTTCACT-
CACCAACC-39; directing the desired mutation and con-
taining the authentic MscI site of the S gene, together
with the antisense primer, “down,” 59-GGGGGAAAGC-
CTAC-39; which corresponds to the C-terminal region of
the S gene (nt 706 to 720). The PCR fragment was
subsequently cut with MscI (nt 305) and SpeI (nt 681) andcloned into pNI2.S and pNI2.L from which the wild-type
fragments have been removed. For construction of mu-
tants Ss61–64 and Ss66–68, the antisense primers,
s61–64, 59-ATACCCGGGACAAGTTGGAGGACAAAGCG-
CTAGTGCGTGATTGGAGGT-39; and s66–68, 59-GTC-
ATACCCGGGACAAGCTAGTGCACAAGAGGTTGG-39; re-
spectively, were employed which contain the mutations
along with an engineered SmaI site. Each PCR mutagen-
esis was done in combination with the sense primer,
“up,” 59-GACGTCTAAGAAACCATTATTATCATGACATT-39,
which hybridizes with vector-derived sequences located
upstream of the S-encoding region. After cleavage of the
amplicons with XhoI (nt 129) and SmaI (nt 366), they were
used to replace the wild-type sequences of a modified
plasmid pNI2.S that carries a genetically silent SmaI site
at nt position 366 of the S gene. Similarly, mutant
Ss70–71 was generated by using the sense primer “up”
nd the mutant primer, s70–71, 59-ACGCCGCAGGCA-
CATCCAGCGATAAGCAGCACAAGTTGG-39, which con-
tains a BsiWI restriction site along with the mutation. As
above, the newly introduced BsiWI site, used for subse-
quent cloning, did not change the S-coding region.
Plasmid pS::Polio contains a modified S gene with a
36-bp insertion at nt position 303 and encodes a hybrid
S protein carrying a 12-amino acid insertion which cor-
responds to a poliovirus type 1 VP1 neutralization
epitope (Delpeyroux et al., 1990).
For in vitro replication of HBV in permissive liver cell
lines, plasmid pHBV was used which carries an 1.1-mer
of the HBV genome (nt 2922 to 84) under the transcrip-
tional control of the hMT IIa promoter (pMH 234/2922;
Radziwill et al., 1990). To prevent expression of the viral
envelope proteins, the translational start codons for the
L, M, and S proteins were inactivated by M13 mutagen-
esis using oligonucleotides M1T, 59-ATTCTGCCCCGT-
GCTGCAGATCTTGTTCCC-39; M109T, 59-CACTGCGTG-
GCCTGAGGA-39; M164T, 59-GATGTTCTCCGTGTTCAGC-
39; respectively. Each antisense primer directed the
substitution of the correspondingly methionine residue
by a threonine residue, thereby leaving the overlapping
reading frame of the viral polymerase unaffected. Appro-
priate fragments carrying the desired mutations were
then cloned into pHBV. The resulting plasmid, deficient to
drive envelope protein synthesis, has been termed
pHBV.env2. In parallel, mutant HBV genomes were con-
tructed in which either S protein (pHBV.S2) or L protein
(pHBV.L2) expression was abolished by knocking out the
S- or L-specific start codons, respectively.
Expression and characterization of the HBV env pro-
teins. To produce viral envelope proteins, transient trans-
fection of COS-7 cells was used. Synthesis and secretion
of the HBV envelope proteins in transfected cells were
analyzed by immunoassay and immunoprecipitation, ex-
actly as described previously (Prange et al., 1992, 1995).
Briefly, 3 days after transfection cellular lysates and su-
pernatants were subjected to ELISA using the Auszyme
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366 LO¨FFLER-MARY ET AL.diagnostic kit (Abbott Laboratories). For immunoprecipi-
tation, transfected cells were metabolically labeled with
[35S]methionine-cysteine and lysed, as described
Prange et al., 1995). Lysates were immunoprecipitated
ith an L-specific polyclonal antiserum which was ob-
ained from rabbits immunized with a bacterially ex-
ressed glutathione S-transferase fusion protein carry-
ng the first 42 amino acids of the L protein (Prange et al.,
995). Immunoprecipitates were then separated by SDS-
AGE and analyzed by PhosphorImager scanning (Mo-
ecular Dynamics).
Detection of cytosolic nucleocapsids and secreted viri-
ns. For virion production, the HuH-7 human hepatoma
ell line was used. HuH-7 cells were seeded at about
3 106 per 10-cm dish 1 day prior to transfection with
HBV-derived plasmids carrying either the wild-type or
utant HBV genome. For cotransfection, pNI2-based
lasmids were added in addition. In order to isolate
ntracellular nucleocapsids from the cytoplasmic fraction
f the cells, cells were lysed on ice for 20 min in 1 ml
ris-buffered saline (TBS, 50 mM Tris-HCl [pH 7.5], 150
M NaCl) supplemented with 5 mM MgCl2 and 0.2%
Triton X-100, 4 days after transfection. Nuclei and cell
debris were removed by centrifugation at 10,000 g for 10
min at 4°C. The core particles were then immunoprecipi-
tated with an anti-hepatitis B core (HBc) antibody (Dako)
which has been precoated to a 10% (wt/vol) suspension
of protein G-agarose (3 ml antibody was bound to 50 ml
agarose solution in an overnight reaction at 4°C). In a
typical experiment, 0.5 ml lysate was incubated with 50
ml anti-HBc-agarose solution overnight at 4°C with rock-
ing. Immunoprecipitates were then washed two times
with TEN-buffer (50 mM Tris-HCl [pH 7.5], 1 mM EDTA, 75
mM NH4Cl) prior to a radioactive endogenous polymer-
ase reaction. Complete viral particles were isolated from
the supernatants of transfected HuH-7 cells by immuno-
precipitation with a mixture (1:1) of polyclonal S- and
L-specific antisera (Prange et al., 1995) which had been
oupled to protein G-agarose, as outlined above. For 10
l of supernatant, a 100 ml slurry of the pretreated
protein G beads was used. Following immunoprecipita-
tion, samples were processed for EPR by dilution in 50 ml
TEN buffer complemented with 20 mM MgCl2, 0.1%
b-mercaptoethanol, 0.5% Nonidet P-40, 0.4 mM of each
dGTP, dCTP, and dTTP, and 10 mCi [a-32P]dATP (3000
Ci/mmol; Amersham) and were incubated overnight at
37°C. To extract the viral DNA, samples were digested
with 20 mg proteinase K in the presence of 0.5% SDS for
1 h at 37°C and were extracted once with a mixture of
phenol:chloroform:isoamyl alcohol (25:24:1) and once
with chloroform:isoamyl alcohol (24:1). Unincorporated
nucleotides were removed by chromatography using
Sephadex G-50 resins (Pharmacia) prior to ethanol pre-
cipitation of the DNA. Labeled HBV genomes were then
separated on 1% agarose gels run in the presence of 1%SDS. After drying, the gels were subjected to Phosphor-
Imager scanning.
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